229 related articles for article (PubMed ID: 17315497)
1. [Neuroleptic malignant syndrome: a life-threatening complication that can be treated effectively].
Rondeel JM
Ned Tijdschr Geneeskd; 2007 Jan; 151(2):154; author reply 154-5. PubMed ID: 17315497
[No Abstract] [Full Text] [Related]
2. [Neuroleptic malignant syndrome: a life-threatening complication that can be treated effectively].
van Waarde JA; Muller ME; Verweg B
Ned Tijdschr Geneeskd; 2006 Nov; 150(46):2517-20. PubMed ID: 17152323
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of hydroxyzine and dexclorfeniramine maleate in combination with electroconvulsive therapy in a neuroleptic malignant catatonia: a case report.
Fernández-Corcuera P; Madre-Rull M; Amann BL
Int Clin Psychopharmacol; 2015 Mar; 30(2):115-7. PubMed ID: 25438028
[TBL] [Abstract][Full Text] [Related]
4. Catatonia and neuroleptic malignant syndrome: two disorders on a same spectrum? Four case reports.
Luchini F; Lattanzi L; Bartolommei N; Cosentino L; Litta A; Kansky C; Mauri M; Cassano GB; Fagiolini A; Casamassima F
J Nerv Ment Dis; 2013 Jan; 201(1):36-42. PubMed ID: 23274293
[TBL] [Abstract][Full Text] [Related]
5. [Lethal catatonia: clinical aspects and therapeutic intervention. A review of the literature].
Mann SC; Auriacombe M; Macfadden W; Caroff SN; Cabrina Campbell E; Tignol J
Encephale; 2001; 27(3):213-6. PubMed ID: 11488250
[TBL] [Abstract][Full Text] [Related]
6. ECT for lorazepam-refractory catatonia.
Yeung PP; Milstein RM; Daniels DC; Bowers MB
Convuls Ther; 1996 Mar; 12(1):31-5. PubMed ID: 8777651
[TBL] [Abstract][Full Text] [Related]
7. Catatonic and non-catatonic neuroleptic malignant syndrome.
Lee JW
Aust N Z J Psychiatry; 2000 Oct; 34(5):877-8. PubMed ID: 11037384
[No Abstract] [Full Text] [Related]
8. Catatonia After Neuroleptic Malignant Syndrome Successfully Treated With Electroconvulsive Therapy.
Che J; Muralidhara S; Egbert M; Sharma A
Prim Care Companion CNS Disord; 2019 Aug; 21(4):. PubMed ID: 31424701
[No Abstract] [Full Text] [Related]
9. A retrospective study of 34 catatonic patients: analysis of clinical care and treatment.
Tuerlings JH; van Waarde JA; Verwey B
Gen Hosp Psychiatry; 2010; 32(6):631-5. PubMed ID: 21112456
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for neuroleptic malignant syndrome.
Francis A; Chandragiri S; Petrides G
Am J Psychiatry; 1998 Nov; 155(11):1639-40. PubMed ID: 9812151
[No Abstract] [Full Text] [Related]
11. Catatonic stupor during the course of Parkinson's disease resolved with electroconvulsive therapy.
Suzuki K; Awata S; Nakagawa K; Takano T; Matsuoka H
Mov Disord; 2006 Jan; 21(1):123-4. PubMed ID: 16250024
[No Abstract] [Full Text] [Related]
12. Malignant catatonia/neuroleptic malignant syndrome or how to change the view on ECT.
Plesnicar BK; But MF; Zalar B
J ECT; 2004 Dec; 20(4):273. PubMed ID: 15591866
[No Abstract] [Full Text] [Related]
13. Electroconvulsive therapy for malignant catatonia in adolescence.
Dhossche DM; Shettar SM; Kumar T; Burt L
South Med J; 2009 Nov; 102(11):1170-2. PubMed ID: 19864990
[TBL] [Abstract][Full Text] [Related]
14. Electroconvulsive therapy for catatonia secondary to neuroleptic malignant syndrome in a patient with multiple sclerosis.
Harley JA; Peebles C; Porter RJ
Aust N Z J Psychiatry; 2019 Jul; 53(7):703-704. PubMed ID: 31072113
[No Abstract] [Full Text] [Related]
15. Catatonia. 2: Diagnosis, management and prognosis.
Clark T; Rickards H
Hosp Med; 1999 Nov; 60(11):812-4. PubMed ID: 10707192
[TBL] [Abstract][Full Text] [Related]
16. Electroconvulsive therapy in drug resistant neuroleptic malignant syndrome.
Patel AL; Shaikh WA; Khobragade AK; Soni HG; Joshi AS; Sahastrabuddhe GS
J Assoc Physicians India; 2008 Jan; 56():49-50. PubMed ID: 18472502
[TBL] [Abstract][Full Text] [Related]
17. Neuroleptic malignant syndrome is malignant catatonia, warranting treatments efficacious for catatonia.
Fink M; Taylor MA
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1182-3; author reply 1184-5. PubMed ID: 16675086
[No Abstract] [Full Text] [Related]
18. Relief by electroconvulsive therapy for postsurgical delirium in malignant catatonia.
Özdemir B; Çelik C; Çinar A; Özşahin A
J ECT; 2010 Dec; 26(4):272-3. PubMed ID: 21155153
[TBL] [Abstract][Full Text] [Related]
19. Malignant catatonia with severe bronchorrhea and its response to electroconvulsive therapy.
Hayashi H; Aoshima T; Otani K
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):310-1. PubMed ID: 16378669
[TBL] [Abstract][Full Text] [Related]
20. Toxic serotonin syndrome or neuroleptic malignant syndrome?
Fink M
Pharmacopsychiatry; 1996 Jul; 29(4):159-61. PubMed ID: 8858716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
